7VEN
Structure of burosumab Fab
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | PAL/PLS BEAMLINE 5C (4A) |
Synchrotron site | PAL/PLS |
Beamline | 5C (4A) |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2021-07-20 |
Detector | ADSC QUANTUM 4 |
Wavelength(s) | 1 |
Spacegroup name | P 1 21 1 |
Unit cell lengths | 49.510, 66.220, 62.050 |
Unit cell angles | 90.00, 105.99, 90.00 |
Refinement procedure
Resolution | 28.949 - 1.450 |
R-factor | 0.1706 |
Rwork | 0.169 |
R-free | 0.19570 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 5ggs |
Data reduction software | XDS |
Data scaling software | XSCALE |
Phasing software | MOLREP |
Refinement software | PHENIX (1.13_2998) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 28.950 | 1.500 |
High resolution limit [Å] | 1.450 | 1.450 |
Number of reflections | 88128 | 8028 |
<I/σ(I)> | 6.3 | |
Completeness [%] | 99.7 | |
Redundancy | 3.4 | |
CC(1/2) | 0.985 | 0.845 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 277 | 0.03M NaF, 0.03M NaBr, 0.03M NaI 0.1M Sodium HEPES, MOPS(acid) pH 7.5 20% v/v PEG500 MME, 10% w/v PEG20000 |